Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. [electronic resource]
Producer: 19950830Description: 336-40 p. digitalISSN:- 0140-6736
- Adult
- Antibodies, Monoclonal -- immunology
- Antigens, CD -- immunology
- B-Lymphocytes -- immunology
- Cohort Studies
- Combined Modality Therapy
- Disease-Free Survival
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation
- Humans
- Iodine Radioisotopes -- administration & dosage
- Lymphoma, B-Cell -- mortality
- Male
- Middle Aged
- Radioimmunotherapy -- adverse effects
- Remission Induction
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.